204 related articles for article (PubMed ID: 16127376)
21. Production and characterization of a monoclonal antibody against an antigen on the surface of non-small cell carcinoma of the lung.
Sharifzadeh S; Modjtahedi H; Jedi Tehrani M; Bayat A; Ghaderi A
Iran J Immunol; 2007 Dec; 4(4):206-14. PubMed ID: 18057578
[TBL] [Abstract][Full Text] [Related]
22. CT and PET imaging in non-small cell lung cancer.
Knoepp UW; Ravenel JG
Crit Rev Oncol Hematol; 2006 Apr; 58(1):15-30. PubMed ID: 16386435
[TBL] [Abstract][Full Text] [Related]
23. [Combined diagnosis of primary lung cancer using immunological tests].
Bakhlaev IE; Oleínik EK; Ageenko AI; Erkhov VS; Trakhtenberg AK
Klin Med (Mosk); 1997; 75(8):45-8. PubMed ID: 9340439
[TBL] [Abstract][Full Text] [Related]
24. [Comparing serum tumor antigen detection combined with CT scan with PET-CT for lung cancer diagnosis].
Zhang X; Li TR; Chen ZS; Ouyang XN
Ai Zheng; 2006 Jan; 25(1):66-8. PubMed ID: 16405752
[TBL] [Abstract][Full Text] [Related]
25. Bone marrow metastases detection in small cell lung cancer. A review.
Trillet-Lenoir VN; Arpin D; Brune J
Anticancer Res; 1994; 14(6B):2795-7. PubMed ID: 7872720
[TBL] [Abstract][Full Text] [Related]
26. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
27. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
Truong MT; Munden RF; Movsas B
J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo targeting properties of iodine-123- or iodine-131-labeled monoclonal antibody 14C5 in a non-small cell lung cancer and colon carcinoma model.
Burvenich I; Schoonooghe S; Cornelissen B; Blanckaert P; Coene E; Cuvelier C; Mertens N; Slegers G
Clin Cancer Res; 2005 Oct; 11(20):7288-96. PubMed ID: 16243799
[TBL] [Abstract][Full Text] [Related]
29. [Antigen phenotype of lung cancer and its relation to chemo-radiosensitivity].
Hida T
Rinsho Byori; 1993 Feb; 41(2):170-3. PubMed ID: 8395611
[TBL] [Abstract][Full Text] [Related]
30. Results of the central data analysis.
Beverley PC; Olabiran Y; Ledermann JA; Bobrow LG; Souhami RL
Br J Cancer Suppl; 1991 Jun; 14():10-9. PubMed ID: 1645565
[TBL] [Abstract][Full Text] [Related]
31. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
[TBL] [Abstract][Full Text] [Related]
32. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
33. Imaging in the diagnosis and treatment of non-small cell lung cancer.
Hicks RJ; Lau E; Alam NZ; Chen RY
Respirology; 2007 Mar; 12(2):165-72. PubMed ID: 17298447
[TBL] [Abstract][Full Text] [Related]
34. CT, positron emission tomography, and MRI in staging lung cancer.
Erasmus JJ; Sabloff BS
Clin Chest Med; 2008 Mar; 29(1):39-57, v. PubMed ID: 18267183
[TBL] [Abstract][Full Text] [Related]
35. Molecular staging and the selection of therapy for non-small cell lung cancer.
D'Amico TA
Semin Thorac Cardiovasc Surg; 2005; 17(3):180-5. PubMed ID: 16253819
[TBL] [Abstract][Full Text] [Related]
36. Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study.
Cerfolio RJ; Bryant AS
J Thorac Cardiovasc Surg; 2008 Feb; 135(2):261-8. PubMed ID: 18242247
[TBL] [Abstract][Full Text] [Related]
37. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M
Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703
[TBL] [Abstract][Full Text] [Related]
38. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
Nestle U; Kremp S; Grosu AL
Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
[TBL] [Abstract][Full Text] [Related]
39. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
[TBL] [Abstract][Full Text] [Related]
40. Re: 'PET-CT in non-small cell lung cancer staging-promises and problems'.
Barnes D; Entwistle J
Clin Radiol; 2008 Jan; 63(1):108-10. PubMed ID: 18068798
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
